aibioPAHC PHIBRO ANIMAL HEALTH CORP
PHIBRO ANIMAL HEALTH CORP (PAHC) news
PHIBRO ANIMAL HEALTH CORP is a public biotech or pharmaceutical company listed on NASDAQ under the ticker PAHC, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Latest PHIBRO ANIMAL HEALTH CORP news
We have not published a story on PHIBRO ANIMAL HEALTH CORP yet. When there is news, it will appear here.
What PHIBRO ANIMAL HEALTH CORP does
Phibro Animal Health is a global animal health and mineral nutrition company. It develops, manufactures and markets products for food animals, including poultry, beef and dairy cattle, swine, aquaculture and dogs, and sells them directly to integrated producers or through feed manufacturers, wholesalers, distributors and veterinarians. Its Animal Health segment includes antibacterials, anticoccidials, nutritional specialty products, and vaccines and vaccine adjuvants that help prevent, control and treat disease. Its Mineral Nutrition segment offers products that fortify the animal diet and help maintain optimal health. Its Performance Products segment makes ingredients for the personal care, industrial chemical and chemical catalyst industries. The company markets about 790 product lines in about 90 countries and says it is investing to develop products for the companion animal sector. In October 2024 it completed its acquisition of Zoetis's medicated feed additive portfolio, which the text says comprises more than 37 product lines sold in about 80 countries, along with six manufacturing sites. Its Class A common stock trades on Nasdaq under the symbol PAHC.
| Product or program | What it is | Stage |
|---|---|---|
| Animal health products | Antibacterials, anticoccidials, nutritional specialty products and vaccines for food animals | |
| Mineral nutrition products | Mineral nutrition products that fortify the animal diet | |
| Performance Products | Ingredients for personal care, industrial chemical and chemical catalyst industries |
PHIBRO ANIMAL HEALTH CORP annual financials
| Line | FY ended Jun 30, 2026 | FY ended Jun 30, 2025 |
|---|---|---|
| Research and development | $24.6 million | $23.7 million |
| Net income (loss) | $99.7 million | $48.3 million |
| Cash from operations | $69.0 million | $80.1 million |
| Cash and equivalents | $61.4 million | $68.0 million |
| Short-term investments | $20.6 million | $9.0 million |
Questions about PHIBRO ANIMAL HEALTH CORP
What is the ticker symbol of PHIBRO ANIMAL HEALTH CORP?
PHIBRO ANIMAL HEALTH CORP trades under the ticker PAHC on NASDAQ.
Where is PHIBRO ANIMAL HEALTH CORP listed?
PHIBRO ANIMAL HEALTH CORP is listed on NASDAQ.
Which country or territory is PHIBRO ANIMAL HEALTH CORP listed under?
Our directory records PHIBRO ANIMAL HEALTH CORP under United States.
Does aibio.space cover PHIBRO ANIMAL HEALTH CORP?
aibio.space lists PHIBRO ANIMAL HEALTH CORP among 2,820 public biotech companies and publishes its news here as stories appear.
What does PHIBRO ANIMAL HEALTH CORP develop?
Phibro Animal Health is a global animal health and mineral nutrition company. It develops, manufactures and markets products for food animals, including poultry, beef and dairy cattle, swine, aquaculture and dogs, and sells them directly to integrated producers or through feed manufacturers, wholesalers, distributors and veterinarians.
What is Animal health products from PHIBRO ANIMAL HEALTH CORP?
Animal health products: Antibacterials, anticoccidials, nutritional specialty products and vaccines for food animals
What is Mineral nutrition products from PHIBRO ANIMAL HEALTH CORP?
Mineral nutrition products: Mineral nutrition products that fortify the animal diet
Is PHIBRO ANIMAL HEALTH CORP profitable?
PHIBRO ANIMAL HEALTH CORP reported net income of $99.7 million for the fiscal year ended Jun 30, 2026, and generated $69.0 million of cash from operations, per its annual report to the SEC.
How much does PHIBRO ANIMAL HEALTH CORP spend on research and development?
$24.6 million in the fiscal year ended Jun 30, 2026, per its annual report.
How much cash does PHIBRO ANIMAL HEALTH CORP have?
$82.0 million in cash and short-term investments at Jun 30, 2026, per its 10-K.
Investor discussion: PHIBRO ANIMAL HEALTH CORP
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Stock chart
Listing details
- Company
- PHIBRO ANIMAL HEALTH CORP
- Ticker
- PAHC
- Listing
- NASDAQ
- Country or territory
- United States
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction